TWI221770B - Medicament for treating hypertension - Google Patents

Medicament for treating hypertension Download PDF

Info

Publication number
TWI221770B
TWI221770B TW089101041A TW89101041A TWI221770B TW I221770 B TWI221770 B TW I221770B TW 089101041 A TW089101041 A TW 089101041A TW 89101041 A TW89101041 A TW 89101041A TW I221770 B TWI221770 B TW I221770B
Authority
TW
Taiwan
Prior art keywords
group
hypertension
phenyl
alkyl
substituted
Prior art date
Application number
TW089101041A
Other languages
English (en)
Chinese (zh)
Inventor
Martin R Wilkins
Dirk Thormaehlen
Harald Waldeck
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Application granted granted Critical
Publication of TWI221770B publication Critical patent/TWI221770B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
TW089101041A 1999-02-16 2000-01-21 Medicament for treating hypertension TWI221770B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19906310A DE19906310A1 (de) 1999-02-16 1999-02-16 Arzneimittel zur Behandlung von Bluthochdruck

Publications (1)

Publication Number Publication Date
TWI221770B true TWI221770B (en) 2004-10-11

Family

ID=7897580

Family Applications (1)

Application Number Title Priority Date Filing Date
TW089101041A TWI221770B (en) 1999-02-16 2000-01-21 Medicament for treating hypertension

Country Status (28)

Country Link
US (1) US6482820B2 (enExample)
EP (1) EP1154777B1 (enExample)
JP (1) JP2002537258A (enExample)
KR (2) KR100797665B1 (enExample)
CN (1) CN1198619C (enExample)
AR (1) AR036864A1 (enExample)
AT (1) ATE295174T1 (enExample)
AU (1) AU773240C (enExample)
BR (1) BR0008260A (enExample)
CA (1) CA2362273C (enExample)
CZ (1) CZ301499B6 (enExample)
DE (2) DE19906310A1 (enExample)
DZ (1) DZ3014A1 (enExample)
ES (1) ES2238268T3 (enExample)
HK (1) HK1042247B (enExample)
HU (1) HUP0105491A3 (enExample)
IL (1) IL144622A (enExample)
NO (1) NO329588B1 (enExample)
NZ (1) NZ514058A (enExample)
PL (1) PL195283B1 (enExample)
PT (1) PT1154777E (enExample)
RU (1) RU2270679C2 (enExample)
SK (1) SK287254B6 (enExample)
TR (1) TR200102386T2 (enExample)
TW (1) TWI221770B (enExample)
UA (1) UA63032C2 (enExample)
WO (1) WO2000048601A1 (enExample)
ZA (1) ZA200105828B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19932555A1 (de) * 1999-07-13 2001-01-18 Solvay Pharm Gmbh Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen
CA2392076A1 (en) * 1999-11-19 2001-05-25 Solvay Pharmaceuticals B.V. Human enzymes of the metalloprotease family
CA2357833C (en) * 2000-10-04 2005-11-15 Warner-Lambert Company Treatment of pulmonary hypertension using vasopressin antagonist
PL367093A1 (en) * 2001-05-18 2005-02-21 Solvay Pharmaceuticals Gmbh Use of compounds with combined nep/mp-inhibitory activity in the preparation of medicaments
PL224030B1 (pl) * 2001-09-10 2016-11-30 Tibotec Pharm Ltd Sposób syntezy heksahydrofuro [2,3-b] furan -3-olu oraz związki pośrednie stosowane w tym sposobie
PL371511A1 (en) 2002-01-16 2005-06-27 Solvay Pharmaceuticals B.V. Solid salts benzazepine compounds and their use in the preparation of pharmaceuticals compounds
AR038681A1 (es) * 2002-02-14 2005-01-26 Solvay Pharm Bv Formulacion oral de solucion solida de una sustancia activa pobremente soluble en agua
WO2004062692A1 (en) * 2003-01-13 2004-07-29 Solvay Pharmaceuticals B.V. Formulation of poorly water-soluble active substances
US7452875B2 (en) 2003-09-26 2008-11-18 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
US7427611B2 (en) 2003-09-26 2008-09-23 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
US7262184B2 (en) 2003-09-26 2007-08-28 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
SA04250283B1 (ar) * 2003-09-26 2008-05-26 سولفاي فارماسيتيكالز جي أم بي أتش مشتقات من amidomethy1-substituted1-(carboxyalkyl)-cyclopentylcarbonylamino-benzazepine-N-acetic acid
AR046454A1 (es) * 2003-11-18 2005-12-07 Solvay Pharm Gmbh Uso de un compuesto de acido benzazepin-n-acetico, composicion farmaceutica, y procedimiento para la produccion de dicha composicion farmaceutica
US20050267124A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous producing system and PDEV inhibiitors
US20050267072A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions containing dually acting inhibitors of neutral endopeptidase for the treatment of sexual dysfunction
US20050288272A1 (en) * 2004-06-23 2005-12-29 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and AT1 receptor antagonists
MX2007006279A (es) 2004-12-15 2007-06-14 Solvay Pharm Gmbh Composiciones farmaceuticas que comprenden inhibidores de nep, inhibidores del sistema de produccion de endotelina endogena, e inhibidores de hmg coa-reductasa.
US20060205625A1 (en) * 2005-02-18 2006-09-14 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics
US20070292503A1 (en) * 2006-06-16 2007-12-20 Gorissen Henricus R Oral pharmaceutical composition of poorly water-soluble active substance
US20070299054A1 (en) * 2006-06-22 2007-12-27 Rajesh Jain Oral pharmaceutical composition of a poorly water-soluble active agent
DK2247297T3 (en) * 2008-01-31 2019-03-11 Univ Vanderbilt THERAPEUTIC TREATMENT OF LUNG CONDITIONS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0254032A3 (en) * 1986-06-20 1990-09-05 Schering Corporation Neutral metalloendopeptidase inhibitors in the treatment of hypertension
US4749688A (en) * 1986-06-20 1988-06-07 Schering Corporation Use of neutral metalloendopeptidase inhibitors in the treatment of hypertension
CA1337400C (en) * 1987-06-08 1995-10-24 Norma G. Delaney Inhibitors of neutral endopeptidase
US5087702A (en) * 1991-01-30 1992-02-11 Merck & Co., Inc. Microbial transformation process for producing an antihypertensive product
US5362727A (en) * 1993-07-26 1994-11-08 Bristol-Myers Squibb Substituted azepino[2,1-a]isoquinoline compounds
DE19510566A1 (de) * 1995-03-23 1996-09-26 Kali Chemie Pharma Gmbh Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19638020A1 (de) * 1996-09-18 1998-03-19 Solvay Pharm Gmbh Die gastrointestinale Durchblutung fördernde Arzneimittel

Also Published As

Publication number Publication date
WO2000048601A1 (de) 2000-08-24
CZ301499B6 (cs) 2010-03-24
DE50010284D1 (de) 2005-06-16
DE19906310A1 (de) 2000-08-17
ZA200105828B (en) 2002-07-15
JP2002537258A (ja) 2002-11-05
NO20013958D0 (no) 2001-08-15
IL144622A (en) 2006-08-20
AR036864A1 (es) 2004-10-13
DZ3014A1 (fr) 2004-03-27
KR100797665B1 (ko) 2008-01-23
HUP0105491A2 (en) 2002-06-29
TR200102386T2 (tr) 2002-01-21
NZ514058A (en) 2001-09-28
EP1154777A1 (de) 2001-11-21
RU2270679C2 (ru) 2006-02-27
KR20010101922A (ko) 2001-11-15
CA2362273C (en) 2010-05-25
BR0008260A (pt) 2001-11-06
UA63032C2 (en) 2004-01-15
SK287254B6 (sk) 2010-04-07
AU773240C (en) 2004-11-18
US6482820B2 (en) 2002-11-19
HUP0105491A3 (en) 2002-08-28
SK10822001A3 (sk) 2002-03-05
HK1042247B (zh) 2005-09-23
HK1042247A1 (en) 2002-08-09
AU773240B2 (en) 2004-05-20
CN1339966A (zh) 2002-03-13
CA2362273A1 (en) 2000-08-24
CN1198619C (zh) 2005-04-27
PL195283B1 (pl) 2007-08-31
EP1154777B1 (de) 2005-05-11
CZ20012672A3 (cs) 2002-02-13
NO329588B1 (no) 2010-11-15
US20020052361A1 (en) 2002-05-02
ES2238268T3 (es) 2005-09-01
ATE295174T1 (de) 2005-05-15
PL350167A1 (en) 2002-11-18
NO20013958L (no) 2001-10-15
AU2547600A (en) 2000-09-04
KR20070027719A (ko) 2007-03-09
PT1154777E (pt) 2005-07-29

Similar Documents

Publication Publication Date Title
TWI221770B (en) Medicament for treating hypertension
TWI823072B (zh) 以２－〔（４－｛６－〔（４－氰基－２－氟苄基）氧基〕吡啶－２－基｝哌啶－１－基）甲基〕－１－〔（２ｓ）－氧雜環丁烷－２－基甲基〕－１ｈ－苯並咪唑－６－甲酸或其藥學上的鹽治療第２型糖尿病或肥胖症或體重過重
CA2644207A1 (en) Pharmaceutical combination composition comprising at least one pkc inhibitor and at least one jak3 kinase inhibitor for treating autoimmune disorders
CN1360502B (zh) 多巴胺d3受体配体在生产肾功能紊乱治疗药物中的应用
CN106132403A (zh) 喷雾干燥制剂
CA3065318A1 (en) Methods for treatment of fibrotic diseases
JP2002537258A5 (enExample)
TW200817000A (en) New paediatric indications for direct thrombin inhibitors
WO2004066998A1 (ja) 安定な経口用固形医薬組成物
JP2007169278A (ja) Ｌｕｔｓ処置用の医薬組合せ
JPH04264030A (ja) 抗喘息剤
CN101460197A (zh) 有机化合物的组合
JPS6045518A (ja) 抗シヨツク剤
TW200526228A (en) Pharmaceutical compositions for the treatment of renal dysfunction, disease or disorder, in particular in diabetic patients
CN101296903A (zh) 新颖含吲哚的β-激动剂、其制备方法及其作为药物的用途
EP3833354B1 (en) Tissue transglutaminase modulators for medicinal use
SK227092A3 (en) Pharmaceutical agent against the high blood pressure
JP2002193813A (ja) デコイを含む薬学的組成物およびその使用方法
JP2002220345A (ja) 脂肪肝改善剤
CN1950360B (zh) 作为蛋白激酶c抑制剂的取代的吡咯-2,5-二酮
JPS6056123B2 (ja) 浮腫・低血圧・心不全および粘膜充血治療用剤
JPH01160920A (ja) 虚血性心臓疾患治療剤
HK40078244A (en) Treatment of type 2 diabetes or obesity or overweight with 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl} piperidin-1-yl)methyl]-1-[(2s)-oxetan-2-ylmethyl]-1h-benzimidazole-6-carboxylic acid or a pharmaceutically salt thereof
AU2009209152A1 (en) A method of administering a PDE3 inhibitor via titration for the treatment of peripheral arterial disease
MXPA01008164A (en) Medicament for treating hypertension

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees